Dorsal Capital Management Has Decreased Its T Mobile Us (TMUS) Stake; Element Capital Management Lowered Its Vital Therapies (VTL) Stake

January 14, 2018 - By Linda Rogers

Element Capital Management Llc decreased Vital Therapies Inc (VTL) stake by 71.15% reported in 2017Q3 SEC filing. Element Capital Management Llc sold 87,449 shares as Vital Therapies Inc (VTL)’s stock declined 32.07%. The Element Capital Management Llc holds 35,463 shares with $179,000 value, down from 122,912 last quarter. Vital Therapies Inc now has $253.24 million valuation. The stock decreased 2.44% or $0.15 during the last trading session, reaching $6. About 149,281 shares traded. Vital Therapies, Inc. (NASDAQ:VTL) has declined 61.75% since January 14, 2017 and is downtrending. It has underperformed by 78.45% the S&P500.

Dorsal Capital Management Llc decreased T Mobile Us Inc (TMUS) stake by 25% reported in 2017Q3 SEC filing. Dorsal Capital Management Llc sold 250,000 shares as T Mobile Us Inc (TMUS)’s stock rose 3.83%. The Dorsal Capital Management Llc holds 750,000 shares with $46.25M value, down from 1.00M last quarter. T Mobile Us Inc now has $52.98B valuation. The stock decreased 0.25% or $0.16 during the last trading session, reaching $63.68. About 3.17M shares traded. T-Mobile US, Inc. (NYSE:TMUS) has risen 62.63% since January 14, 2017 and is uptrending. It has outperformed by 45.93% the S&P500.

Investors sentiment decreased to 1.06 in 2017 Q3. Its down 0.30, from 1.36 in 2017Q2. It is negative, as 62 investors sold TMUS shares while 161 reduced holdings. 67 funds opened positions while 169 raised stakes. 279.18 million shares or 0.29% more from 278.36 million shares in 2017Q2 were reported. Credit Suisse Ag owns 726,552 shares. The New York-based M&T Natl Bank Corp has invested 0.02% in T-Mobile US, Inc. (NASDAQ:TMUS). Nomura Holdg Inc holds 232,553 shares. American National Registered Invest Advisor holds 0.23% or 7,405 shares. Moreover, Overbrook Mngmt has 4.18% invested in T-Mobile US, Inc. (NASDAQ:TMUS) for 299,613 shares. Moreover, D E Shaw has 0.58% invested in T-Mobile US, Inc. (NASDAQ:TMUS) for 6.10M shares. 94,668 are held by Gulf Int Commercial Bank (Uk) Ltd. Dekabank Deutsche Girozentrale holds 0.2% in T-Mobile US, Inc. (NASDAQ:TMUS) or 401,300 shares. Moreover, Proshare Advsr has 0.15% invested in T-Mobile US, Inc. (NASDAQ:TMUS) for 268,032 shares. De Burlo Gru Inc reported 1.09% in T-Mobile US, Inc. (NASDAQ:TMUS). Nuveen Asset Mgmt Ltd Company has 65,915 shares. Highstreet Asset invested in 21,909 shares. Moreover, Tiaa Cref Mngmt Limited Liability Com has 0.18% invested in T-Mobile US, Inc. (NASDAQ:TMUS) for 4.18M shares. Utd Automobile Association has 378,943 shares for 0.07% of their portfolio. Vident Invest Advisory Limited Company invested in 41,093 shares or 0.14% of the stock.

Among 32 analysts covering T-Mobile US (NYSE:TMUS), 26 have Buy rating, 1 Sell and 5 Hold. Therefore 81% are positive. T-Mobile US had 71 analyst reports since August 3, 2015 according to SRatingsIntel. The company was upgraded on Tuesday, November 21 by HSBC. The firm earned “Hold” rating on Friday, June 23 by Credit Suisse. The firm has “Buy” rating given on Thursday, August 10 by Oppenheimer. RBC Capital Markets maintained T-Mobile US, Inc. (NASDAQ:TMUS) on Monday, August 28 with “Buy” rating. The rating was downgraded by Nomura to “Neutral” on Friday, June 24. Raymond James maintained the shares of TMUS in report on Thursday, July 20 with “Buy” rating. FBR Capital maintained T-Mobile US, Inc. (NASDAQ:TMUS) on Tuesday, October 25 with “Mkt Perform” rating. RBC Capital Markets maintained T-Mobile US, Inc. (NASDAQ:TMUS) rating on Wednesday, February 15. RBC Capital Markets has “Outperform” rating and $69 target. The firm earned “Buy” rating on Wednesday, April 26 by William Blair. BTIG Research maintained T-Mobile US, Inc. (NASDAQ:TMUS) on Tuesday, August 2 with “Buy” rating.

Analysts await T-Mobile US, Inc. (NASDAQ:TMUS) to report earnings on February, 13. They expect $0.33 earnings per share, down 26.67% or $0.12 from last year’s $0.45 per share. TMUS’s profit will be $274.55M for 48.24 P/E if the $0.33 EPS becomes a reality. After $0.63 actual earnings per share reported by T-Mobile US, Inc. for the previous quarter, Wall Street now forecasts -47.62% negative EPS growth.

Among 7 analysts covering Vital Therapies Inc (NASDAQ:VTL), 3 have Buy rating, 0 Sell and 4 Hold. Therefore 43% are positive. Vital Therapies Inc had 12 analyst reports since August 7, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Monday, August 10 by Credit Suisse. The firm has “Buy” rating given on Monday, August 24 by SunTrust. BTIG Research initiated Vital Therapies, Inc. (NASDAQ:VTL) rating on Friday, August 7. BTIG Research has “Buy” rating and $23 target. The firm has “Neutral” rating given on Monday, August 24 by Credit Suisse. The rating was downgraded by Suntrust Robinson to “Neutral” on Monday, August 24. The firm has “Neutral” rating by SunTrust given on Tuesday, September 29. The firm has “Neutral” rating given on Monday, October 26 by BTIG Research. As per Monday, August 24, the company rating was downgraded by William Blair. As per Tuesday, September 29, the company rating was downgraded by Suntrust Robinson. The rating was maintained by Canaccord Genuity on Monday, August 24 with “Buy”.

Investors sentiment increased to 0.82 in Q3 2017. Its up 0.06, from 0.76 in 2017Q2. It increased, as 8 investors sold VTL shares while 14 reduced holdings. 8 funds opened positions while 10 raised stakes. 9.66 million shares or 5.18% less from 10.19 million shares in 2017Q2 were reported. Goldman Sachs Gp owns 12,717 shares. Victory Mgmt owns 2.60 million shares. Bnp Paribas Arbitrage Sa reported 0% in Vital Therapies, Inc. (NASDAQ:VTL). Bridgeway Mgmt, a Texas-based fund reported 175,000 shares. Meeder Asset Mgmt reported 1,043 shares stake. Geode Limited Liability Corp, a Massachusetts-based fund reported 174,738 shares. Bancorp Of America De reported 2,550 shares. Fmr Ltd Llc owns 2.96 million shares or 0% of their US portfolio. Jane Street Grp Lc has invested 0% of its portfolio in Vital Therapies, Inc. (NASDAQ:VTL). Jpmorgan Chase accumulated 0% or 25,462 shares. Renaissance Ltd Liability Co owns 54,400 shares. State Street Corporation invested 0% in Vital Therapies, Inc. (NASDAQ:VTL). Tower Research Limited Liability (Trc) holds 0% of its portfolio in Vital Therapies, Inc. (NASDAQ:VTL) for 8,800 shares. Northern reported 0% stake. Macroview Invest Mgmt Limited Liability Corporation has 0% invested in Vital Therapies, Inc. (NASDAQ:VTL) for 32 shares.

Analysts await Vital Therapies, Inc. (NASDAQ:VTL) to report earnings on March, 6. They expect $-0.30 earnings per share, up 18.92% or $0.07 from last year’s $-0.37 per share. After $-0.30 actual earnings per share reported by Vital Therapies, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>